Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research focused on Socioeconomic status and Oncology, with related work in Trk receptor, Pembrolizumab, Hazard ratio. Notable publications include 'Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022', 'TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting', and 'Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types'.